EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieMultizentrische StudieOpen Access · CC BY 4.0

Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation

Babar Khan, Darab Shuja, Burhan Ul Haq Saqib, Maria Liaquat, Jahanzeb Malik, Amna Ashraf, Ali Karim, Iftikhar Ahmed, Waheed Akhtar, Amin Mehmoodi

Clinical Cardiology · 2024

DOI: 10.1002/clc.70033 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Babar Khan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Lady Reading Hospital, Peshawar, Pakistan. Hauptthemen laut MEDLINE: Furosemide, Heart Failure, Atrial Fibrillation, Diuretics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This prospective, randomized trial aimed to compare the efficacy and safety of different intravenous diuretic regimens in acute decompensated heart failure (ADHF) patients.

Methods

ADHF patients were enrolled and randomized into three groups: continuous intravenous furosemide infusion (cIV), bolus furosemide injection (bI), and furosemide plus hypertonic saline solution (HSS). Clinical outcomes were assessed over 48 h.

Results

In a study involving 1276 patients admitted for ADHF, three therapeutic regimens (T × 1, T × 2, and T × 3) were compared. T × 1 administered an 80 mg furosemide intravenous bolus infusion twice daily to 479 patients, while T × 2 involved a continuous 16‐h infusion of 160 mg furosemide daily to 420 patients. T × 3 treated 377 patients with 160 mg furosemide combined with 150 mL of HSS containing 1.95% NaCl over 30 min. Yet, overall changes in renal markers such as BUN, Na, K, and serum creatinine did not differ significantly. Analysis of prespecified study endpoints revealed notable variations in hospitalization length among the treatment arms. T × 1 demonstrated a significantly shorter hospital stay (3.7 days) compared to T × 2 (6.6 days) and T × 3 (7.9 days). Conversely, alterations in serum creatinine at 48 h, overall changes in serum creatinine, body weight loss, and serum potassium levels did not significantly differ among the treatment groups.

Conclusion

While intravenous bolus of furosemide showed potential benefits in reducing hospitalization duration, limitations such as a small sample size and short‐term observation emphasize the need for larger studies to validate these outcomes further.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FurosemideHeart FailureAtrial FibrillationDiureticsHumansFemaleMaleInfusions, IntravenousAgedProspective StudiesTreatment OutcomeAcute DiseaseMiddle AgedInjections, IntravenousTime FactorsVentricular Function, LeftSaline Solution, HypertonicAged, 80 and over

Stichwörter der Autor:innen

acute decompensated heart failurediuretic regimensfurosemidehypertonic saline solutionrenal function

Substanzen

FurosemideDiureticsSaline Solution, Hypertonic

Autor:innen und Institutionen

  • Department of Cardiology, Lady Reading Hospital, Peshawar, Pakistan.
  • Department of Medicine, Services Hospital, Lahore, Pakistan.
  • Department of Cardiology, DHQ Hospital, Mirpur, Pakistan.
  • Department of Medicine, Benazir Bhutto Hospital, Rawalpindi, Pakistan.
  • Department of Cardiovascular Medicine, Cardiovascular Analytics Group, Islamabad, Pakistan.
  • Department of Medicine, Military Hospital, Rawalpindi, Pakistan.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Khan, B., Shuja, D., Saqib, B. U. H., Liaquat, M., Malik, J., Ashraf, A., Karim, A., Ahmed, I., Akhtar, W., & Mehmoodi, A. (2024). Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation. Clinical Cardiology. https://doi.org/10.1002/clc.70033

Vancouver

Khan B, Shuja D, Saqib BUH, Liaquat M, Malik J, Ashraf A, et al. Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation. Clinical Cardiology. 2024. doi:10.1002/clc.70033

BibTeX
@article{Khan2024,
  author = {Khan, Babar and Shuja, Darab and Saqib, Burhan Ul Haq and Liaquat, Maria and Malik, Jahanzeb and Ashraf, Amna and Karim, Ali and Ahmed, Iftikhar and Akhtar, Waheed and Mehmoodi, Amin},
  title = {Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation},
  journal = {Clinical Cardiology},
  year = {2024},
  doi = {10.1002/clc.70033}
}
Kostenlos starten →